A multiomic approach for detecting clinically significant prostate cancer in seminal fluid: Results from a large multicenter clinical study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

With early detection of prostate cancer recognised as a critical part in reducing the disease’s mortality rate, PanGIA ...

Johnson & Johnson has reported data from a Phase I trial of pasritamig for metastatic castration-resistant prostate cancer ...

Scientists say they have worked out a machine learning method with the ability to provide close to precise survival estimates of patients afflicted ...

177Lu-PSMA-617 consolidation therapy post docetaxel in patients with de-novo high-volume metastatic hormone-sensitive prostate cancer: A randomized, phase 2 trial. Outcomes of initial vs delayed ...

This finding implicates that targeting PCNA/AR interaction could be an innovative strategy for therapy against CRPC."BUFFALO, ...

Prostate cancer is the fourth most common cancer among men in India. Often symptomless in its early stages, it is highly ...

Former President Joe Biden has been diagnosed with an "aggressive" form of prostate cancer that has spread to his bones. But ...

For the local Prostate Cancer Support Group, which this year is celebrating its 25th Silver Anniversary, Biden’s diagnosis ...

Doctors examine a tumor in several different ways to determine whether a cancer is aggressive – and what kinds of treatments, ...

Astellas and Pfizer's Xtandi plus ADT showed a decrease in mortality risk in a metastatic hormone-sensitive prostate cancer ...